Update on the Incidence and Prevalence of Inflammatory Bowel Disease in the United States.
作者信息
Loftus Edward V
机构信息
Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic Rochester, Minnesota.
出版信息
Gastroenterol Hepatol (N Y). 2016 Nov;12(11):704-707.
Abstract
摘要
相似文献
1
Update on the Incidence and Prevalence of Inflammatory Bowel Disease in the United States.美国炎症性肠病发病率和患病率的最新情况
Gastroenterol Hepatol (N Y). 2016 Nov;12(11):704-707.
2
An Update on Inflammatory Bowel Disease.炎症性肠病的最新进展
Prim Care. 2017 Dec;44(4):673-692. doi: 10.1016/j.pop.2017.07.010. Epub 2017 Oct 5.
3
Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.英国炎症性肠病的流行病学和结局变化模式：2000-2018 年。
Aliment Pharmacol Ther. 2020 May;51(10):922-934. doi: 10.1111/apt.15701. Epub 2020 Apr 1.
4
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率：基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
5
The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease.美国炎症性肠病退伍军人全国队列中焦虑、抑郁和创伤后应激障碍的发生率和流行率。
Inflamm Bowel Dis. 2020 Aug 20;26(9):1423-1428. doi: 10.1093/ibd/izz280.
6
Bidirectional relationship between atopic dermatitis and inflammatory bowel disease: A systematic review and meta-analysis.特应性皮炎与炎症性肠病的双向关系：系统评价和荟萃分析。
J Am Acad Dermatol. 2020 Nov;83(5):1385-1394. doi: 10.1016/j.jaad.2020.05.130. Epub 2020 Jun 1.
7
Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil.巴西圣保罗州中西部炎症性肠病的发病率和患病率
Arq Gastroenterol. 2009 Jan-Mar;46(1):20-5. doi: 10.1590/s0004-28032009000100009.
8
A comprehensive review and update on Crohn's disease.克罗恩病的全面综述与更新
Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001. Epub 2017 Aug 18.
9
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.《2018年炎症性肠病在加拿大的影响：流行病学》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.
10
Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.1970年至2010年明尼苏达州奥尔姆斯特德县克罗恩病和溃疡性结肠炎的发病率及患病率
Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863. doi: 10.1016/j.cgh.2016.10.039. Epub 2016 Nov 14.
引用本文的文献
1
Association between the immune-inflammation index and the severity and clinical outcomes of patients with inflammatory bowel disease: a systematic review and meta-analysis.免疫炎症指数与炎症性肠病患者的严重程度及临床结局之间的关联：一项系统评价和荟萃分析
BMC Gastroenterol. 2025 May 29;25(1):414. doi: 10.1186/s12876-025-04033-4.
2
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.靶向炎症递送尿石素 A 可减轻化学和免疫检查点抑制剂诱导的结肠炎。
J Nanobiotechnology. 2024 Nov 13;22(1):701. doi: 10.1186/s12951-024-02990-8.
3
Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series.粪便白细胞酯酶：炎症性肠病中粪便钙卫蛋白的替代生物标志物——一项初步系列研究
Gastro Hep Adv. 2022 Feb 3;1(1):45-51. doi: 10.1016/j.gastha.2021.10.006. eCollection 2022.
4
Impact of Obesity and Metabolic Syndrome on IBD Outcomes.肥胖症和代谢综合征对炎症性肠病结局的影响。
Dig Dis Sci. 2024 Aug;69(8):2741-2753. doi: 10.1007/s10620-024-08504-8. Epub 2024 Jun 12.
5
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.炎症性肠病模仿症的临床决策：来自炎症性肠病现场会议的实践管理
Crohns Colitis 360. 2024 Apr 11;6(2):otae022. doi: 10.1093/crocol/otae022. eCollection 2024 Apr.
6
Prevalence, incidence, and treatment patterns of fistulizing Crohn disease: A US population-based cohort study.瘘管性克罗恩病的患病率、发病率及治疗模式：一项基于美国人群的队列研究。
J Manag Care Spec Pharm. 2024 May;30(5):420-429. doi: 10.18553/jmcp.2024.30.5.420.
7
Correlation of Socioeconomic and Environmental Factors With Incidence of Crohn Disease in Children and Adolescents: Systematic Review and Meta-Regression.社会经济和环境因素与儿童和青少年克罗恩病发病率的相关性：系统评价和荟萃回归分析。
JMIR Public Health Surveill. 2024 Mar 25;10:e48682. doi: 10.2196/48682.
8
Mucosal DNA methylome alteration in Crohn's disease: surgical and non-surgical groups.克罗恩病黏膜DNA甲基化组改变：手术组与非手术组
Front Genet. 2023 Nov 17;14:1244513. doi: 10.3389/fgene.2023.1244513. eCollection 2023.
9
Evolving Trends and Burden of Inflammatory Bowel Disease in Asia, 1990-2019: A Comprehensive Analysis Based on the Global Burden of Disease Study.亚洲炎症性肠病的演变趋势和负担，1990-2019：基于全球疾病负担研究的综合分析。
J Epidemiol Glob Health. 2023 Dec;13(4):725-739. doi: 10.1007/s44197-023-00145-w. Epub 2023 Sep 1.
10
Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study.英夫利昔单抗加速输注安全性和耐受性在炎症性肠病患者中不劣于标准输注方案：一项随机对照研究
Crohns Colitis 360. 2023 May 3;5(3):otad022. doi: 10.1093/crocol/otad022. eCollection 2023 Jul.
本文引用的文献
1
Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.1970年至2010年明尼苏达州奥尔姆斯特德县克罗恩病和溃疡性结肠炎的发病率及患病率
Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863. doi: 10.1016/j.cgh.2016.10.039. Epub 2016 Nov 14.
2
The global burden of IBD: from 2015 to 2025.IBD 的全球负担：2015 年至 2025 年。
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7. doi: 10.1038/nrgastro.2015.150. Epub 2015 Sep 1.
3
Epidemiology of inflammatory bowel disease in Québec: recent trends.魁北克炎症性肠病的流行病学：近期趋势
Inflamm Bowel Dis. 2014 Oct;20(10):1770-6. doi: 10.1097/MIB.0000000000000162.
4
Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study.加拿大东部炎症性肠病发病率下降：一项基于人群数据库的研究。
BMC Gastroenterol. 2014 Aug 9;14:140. doi: 10.1186/1471-230X-14-140.
5
Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States.美国炎症性肠病的流行率存在种族/民族和地区差异。
Digestion. 2013;88(1):20-5. doi: 10.1159/000350759. Epub 2013 Jun 22.
6
Geographical variability and environmental risk factors in inflammatory bowel disease.炎症性肠病的地域变异性和环境风险因素。
Gut. 2013 Apr;62(4):630-49. doi: 10.1136/gutjnl-2012-303661. Epub 2013 Jan 18.
7
Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.1996 - 2002年北加利福尼亚一个管理式医疗组织中炎症性肠病的发病率和患病率
Am J Gastroenterol. 2008 Aug;103(8):1998-2006. doi: 10.1111/j.1572-0241.2008.01960.x.
8
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States.美国克罗恩病和溃疡性结肠炎的患病率及地理分布。
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1424-9. doi: 10.1016/j.cgh.2007.07.012. Epub 2007 Sep 29.
9
Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.利用计算机诊断和门诊药房配药情况估算九个健康计划中炎症性肠病的期间患病率。
Inflamm Bowel Dis. 2007 Apr;13(4):451-61. doi: 10.1002/ibd.20021.
10
Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.明尼苏达州奥姆斯特德县克罗恩病和溃疡性结肠炎发病率及患病率的最新情况，1940 - 2000年
Inflamm Bowel Dis. 2007 Mar;13(3):254-61. doi: 10.1002/ibd.20029.
Zotero 插件